Content of review 1, reviewed on November 16, 2020

The authors have presented an interesting article that takes an evolutionary biology approach towards the future application of phages. I did struggle at times with this article, mainly with its pitch and messaging. While I enjoyed aspects of the writing, other statements and parts were confusing or were not justified (see detailed comments particularly in discussion). The majority of the article was acceptable, with many of the points being covered in other reviews/summaries, but it is unclear how and where the authors draw some of their conclusions considering the majority of the text does not support this.

Further, it was very difficult to review and leave detailed line by line comments without line numbering, so all my comments are in pdf

Source

    © 2020 the Reviewer.

Content of review 2, reviewed on May 09, 2021

I'd like to thank the authors for their time and work on this revision. The resubmitting article is much clearer, easier to read, and I can follow and understand the logic of their argument, which was not always evident in the previous manuscript. The English and grammar has also been cleaned up, which I think was the basis for many of my previous comments.

The abstract and the conclusion in particular are much better and I think they solidify the article, clearly outlining the hypothesis and arguments proposed, as well as summarising the major conclusions and references for the article. My only suggestion would be to consider including a recent manuscript of ours (Gordillo et al. 2021 Nat. Micro.) as an additional reference to support the resensitation and targeting of virulence factors by characterised phages.

Jeremy Barr

Source

    © 2021 the Reviewer.

References

    Remy, F., Charlotte, B. 2021. Evolutionary biology and development model of medicines: A necessary 'pas de deux' for future successful bacteriophage therapy. Journal of Evolutionary Biology.